{
  "units": [
    {
      "title": "Inhibitor treatment of organoids",
      "text": "were treated with inhibitors to either NOTCH (DBZ or DAPT) or WNT (IWP-2 or XAV939) upon initiation of hormonal stimulation.",
      "rationale": "Describes the experimental step of adding specific pathway inhibitors during hormone exposure.",
      "detected_categories": [],
      "split_audit": {
        "char_count": 124,
        "word_count": 21,
        "sentence_count": 1,
        "category_count": 0,
        "flags": [
          "UNIT_NO_EXPERIMENT_CATEGORY"
        ]
      }
    },
    {
      "title": "Omission of RSPO-1 in WNT inhibition condition",
      "text": "R-spondin-1 (RSPO-1) was omitted from ExM in the presence of WNT inhibitors.\nIHC for acetylated Î±-tubulin (ciliary marker) and glycodelin (PAEP).\nCollection time points for scRNA-seq are highlighted with asterisks.",
      "rationale": "Specifies a modification of the culture medium when WNT signaling is blocked.",
      "detected_categories": [],
      "split_audit": {
        "char_count": 214,
        "word_count": 35,
        "sentence_count": 3,
        "category_count": 0,
        "flags": [
          "UNIT_NO_EXPERIMENT_CATEGORY"
        ]
      }
    }
  ],
  "created_at": "2026-02-17T07:30:10.600886+00:00"
}